Compare NICE Ltd (NICE) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Tilray Brands Inc — how do they compare? NICE Ltd trades at $98.12 (market cap $5.94B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: NICE Ltd is far larger — about 10× Tilray Brands Inc's market cap, and NICE Ltd is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| NICE | TLRY | |
|---|---|---|
Market Cap | $5.94B | $591.60M |
Sector | Technology | Health |
52-Week High | $153.44 | $21.00 |
52-Week Low | $83.15 | $3.88 |
Enterprise Value | $5.67B | $758.73M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NICE stock trades at $101.47, down 3.82% in the last session, reflecting near-term bearish technical signals. The company maintains strong fundamentals with a P/E of 14.77 and robust profitability, including a 65.12% gross margin and consistent earnings beats in recent quarters. Recent news highlights AI platform deployments with major clients like AOK PLUS and Bluecrest, reinforcing growth in the CX segment. Analyst consensus remains positive with a $118.67 price target, though technical indicators suggest caution amid a bearish overall signal.
The outlook for NICE is supported by solid cloud and AI revenue growth, upward EPS guidance, and a debt-light balance sheet. Key risks include execution challenges in scaling AI offerings and competitive pressures in the customer engagement software market. With no sell ratings from analysts and institutional accumulation, the stock presents a value opportunity for long-term investors despite near-term volatility.
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
